HomeCompareEMHTF vs JEPQ

EMHTF vs JEPQ: Dividend Comparison 2026

EMHTF yields 4938.27% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMHTF wins by $55146348937607.20M in total portfolio value
10 years
EMHTF
EMHTF
● Live price
4938.27%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55146348937607.24M
Annual income
$53,033,758,961,414,200,000.00
Full EMHTF calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — EMHTF vs JEPQ

📍 EMHTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMHTFJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMHTF + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMHTF pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMHTF
Annual income on $10K today (after 15% tax)
$419,753.09/yr
After 10yr DRIP, annual income (after tax)
$45,078,695,117,202,070,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, EMHTF beats the other by $45,078,695,117,202,070,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMHTF + JEPQ for your $10,000?

EMHTF: 50%JEPQ: 50%
100% JEPQ50/50100% EMHTF
Portfolio after 10yr
$27573174468803.64M
Annual income
$26,516,879,480,707,100,000.00/yr
Blended yield
96.17%
📊

Analyst Conviction Gap

Where Wall Street is split right now

EMHTF
Analyst Ratings
1
Hold
Consensus: Hold
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMHTF buys
0
JEPQ buys
0
No recent congressional trades found for EMHTF or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMHTFJEPQ
Forward yield4938.27%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$55146348937607.24M$44.8K
Annual income after 10y$53,033,758,961,414,200,000.00$2,152.59
Total dividends collected$55003355952995.54M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: EMHTF vs JEPQ ($10,000, DRIP)

YearEMHTF PortfolioEMHTF Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$504,527$493,827.16$11,930$1,110.39+$492.6KEMHTF
2$23,824,817$23,284,973.37$14,133$1,224.34+$23.81MEMHTF
3$1,053,123,085$1,027,630,530.32$16,632$1,340.46+$1053.11MEMHTF
4$43,579,292,978$42,452,451,277.21$19,454$1,457.97+$43579.27MEMHTF
5$1,688,429,051,261$1,641,799,207,774.13$22,626$1,576.08+$1688429.03MEMHTF
6$61,254,845,187,941$59,448,226,103,092.12$26,175$1,694.09+$61254845.16MEMHTF
7$2,081,181,684,947,090$2,015,639,000,595,993.00$30,133$1,811.32+$2081181684.92MEMHTF
8$66,229,598,087,621,200$64,002,733,684,727,816.00$34,531$1,927.17+$66229598087.59MEMHTF
9$1,974,383,155,320,608,300$1,903,517,485,366,853,600.00$39,403$2,041.08+$1974383155320.57MEMHTF
10$55,146,348,937,607,240,000$53,033,758,961,414,200,000.00$44,787$2,152.59+$55146348937607.20MEMHTF

EMHTF vs JEPQ: Complete Analysis 2026

EMHTFStock

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. As of November 10, 2022, Emerald Health Therapeutics, Inc. operates as a subsidiary of Skye Bioscience, Inc.

Full EMHTF Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this EMHTF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMHTF vs SCHDEMHTF vs JEPIEMHTF vs OEMHTF vs KOEMHTF vs MAINEMHTF vs XYLDEMHTF vs QYLDEMHTF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.